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Abstract 
Introduction: Hyperglycemia is the condition that if the body has high blood sugar levels, it results in 
the insulin resistance and inflammation within the body. It can increase the level of inflammatory 
markers suchas hs-CRP and homocysteine in the blood. Both hs-CRP and homocysteine are involved in 
inflammation within the body and also are associated with arteriosclerosis diseases such as coronary 
artery disease, stroke, and peripheral vascular disease. 
Objectives: To study the association between HbA1C and inflammatory markers levels including hs-
CRP and homocysteine.  
Methods: About 90 cases, ages between 35 and 65 years were collected data from the Bangkok Anti-
Aging Center’s medical recording between July 2019 and March 2020. Independent variable was HbA1c 
and the dependent variables were hs-CRP and Homocysteine. Pearson’s correlation coefficient was used 
to detect the correlations between HbA1c and hs-CRP and Homocysteine. 
Results: HbA1c was positively correlated with hs-CRP in the blood with statistically significant (r = 
0.33, p = 0.001) and HbA1C also was positively correlated with homocysteine with statistically 
significant (r = 0.53, p <0.001). In addition, BMI was positively correlated with hs-CRP, and 
homocysteine with statistically significant r = 0.33, p = 0.002; 0.32, p = 0.002, respectively.   
Conclusion: High levels of inflammatory markers were found not only in those diagnosed with diabetes 
but in those with HbA1C diagnosed with pre-diabetes which were found to have high inflammatory 
markers as well. Therefore, if we can control HbA1C to normal level (HbA1C < 5.7) without focusing 
only on people with diabetes but in people who are pre-diabetes by adjusting diet and exercise to keep 
HbA1C and weight to a normal level, it can help to reduce inflammation within the body and blood 
vessels and help to reduce arteriosclerosis in the future. This is an important and common complication 
in patients with hyperglycemia as well. 
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 Inflammation is the leading factor in 
atherosclerosis and coronary artery disease by 
stimulating arterial thrombosis (Silva and de 
Lacerda, 2012). There are many inflammatory 
markers indicating that inflammation in the body, but 
high-sensitivity C-reactive protein (hs-CRP) is the 
best inflammatory marker indicating the risk of 
arteriosclerosis both in the prevention and treatment 
of disease (Koenig, 2013). CRP is generated from the 
liver after being stimulated by IL-6 and IL-1β when 
inflammation occurs. CRP can be measured in the 
range 10-1,000 mg/L but high-sensitivity C-reactive 
protein (hs-CRP) can be measured as low as 0.3 mg/L 
which is sensitive and correlated to coronary artery 
disease in the future. It is useful for assessing the risk 
of coronary heart disease (Ramesh et al., 2019). 
 
 Homocysteine is a sulfur-containing amino 
acid. Homocysteine is a metabolite obtained from the 
process of demethylation of the amino acid 
methionine which is found primarily in animal 
protein. Homocysteine plays a role in the reaction of 
transmethylation of protein metabolism. There are 
several studies that have found that high 
homocysteine (Hyperhomocysteine) increases the 
risk of cardiovascular disease including premature 
coronary artery disease, stroke, and venous 
thromboembolism although the patient had normal 
lipid levels (Stampfer et al., 1992). In addition, the 
abnormality of increased blood homocysteine 
(Hyperhomocysteine) levels was reported in those 
who had Insufficient intake of vitamin B6 
(pyridoxine), B12 (cobalamin), and folic acid (Currò 
et al., 2014). 
 HbA1c is a form of hemoglobin. HbA1c in the 
patient's blood can reflect the patient's control of 
diabetes over the past three months. Which is the 
mean age of red blood cells (Bonora and Tuomilehto, 
2011). HbA1c is currently used in the diagnosis of 
diabetes according to the American Diabetes 
Association (ADA) guideline 2018 and the American 
Association of Clinical Endocrinologists. By 
interpreting the HbA1c as follows, HbA1c <5.7% 
means non-diabetes, HbA1c = 5.7 - 6.4% means that 
there is a risk of diabetes (Pre-diabetes) and HbA1c 
≥ 6.5% means Diabetes. 
 
 High-sensitivity C-reactive protein (hs-CRP) 
levels were statistically positively correlated with 
HbA1c in people with poor sugar control. This is 
because hyperglycemia leads to inflammation. 
Glycation is the cause of the inflammatory process 
which leads to an increase in High-sensitivity C-
reactive protein (hs-CRP) (Ahmed, 2018). Based on 
research by Amanullah et al. (2010) found that High-
sensitivity C-reactive protein (hs-CRP) is high in 
people with insulin resistance with statistically 
significant (p < 0.001) and High-sensitivity C-
reactive protein (hs-CRP) was found to be higher in 
people with diabetes than in non-diabetic people with 
statistically significant (p < 0.001). Correspond to the 
research of Ahmed (2018) which found a significant 
positive relationship between HbA1c and CRP in 
patients with coronary heart disease (p = 0.001). In 
addition, high HbA1c, high CRP, and diabetes were 
found to be statistically significant (p < 0.05). 
Research by Bansal et al. (2016) found that there was 
an increase in homocysteine in patients with Type 2 
diabetes mellitus compared to the non-diabetic group 
with statistically significant. Correspond to the 
research by Drzewoski et al. (2000) which found that 
diabetic patients had an increase in homocysteine 
with statistically significant (p <0.05). 
 Since there is little information available about 
the study of HbA1c effects to inflammatory markers 
with vascular inflammation (high-sensitivity C-
reactive protein (hs-CRP) and homocysteine) in 
Thailand. Thus, this study was conducted to study the 
effect of HbA1c with inflammatory markers: High-
sensitivity C-reactive protein (hs-CRP) and 
homocysteine, for the benefit of patients with 
hyperglycemia to predict and prevent 
arteriosclerosis.  
Materials and Methods 
Study design 
 This analytical research aimed to study in two 
objectives, firstly the correlation between 
Hemoglobin A1C (HbA1C) and High-sensitivity C-
reactive protein (hs-CRP) in the blood and also to 
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study the correlation between Hemoglobin A1C 
(HbA1C) and Homocysteine in the blood. 
 
Study participants 
 Ninety cases were collected data from the 
Bangkok Anti-Aging Center’s medical records 
between July 2019 and March 2020. The inclusion 
criteria of the patients in the present study were 
patients who were 35 – 65 years. The exclusion 
criteria were patients who drank more than 2 
alcoholic drinks per week, smoking, high-sensitivity 
C-reactive protein (hs-CRP) ≥ 10 mg/L, history of 
atherosclerosis disease such as coronary artery 
diseases, cerebrovascular disease (Stroke), and 
peripheral vascular disease. 
 
Ethics 
 This study only used the number of patients 




 Selection of 90 cases, ages between 35 and 65 
years, were collected data from the Bangkok Anti-
Aging Center’s medical records between July 2019 
and March 2020 according to the inclusion criteria 
and exclusion criteria. Blood results were collected 
from the patient's medical record including blood 
glucose (HbA1C) data, inflammatory markers (high-
sensitivity C-reactive protein (hs-CRP), and 
homocysteine), renal function (Creatinine), and liver 
function tests (AST, ALT). Basic patient information 
such as gender, age, BMI, and blood pressure were 




 The independent variable was HbA1c. The 
dependent variables were hs-CRP and homocysteine. 
Pearson’s correlation coefficient was used to detect 
the correlations between HbA1c and hs-CRP and 




Results and Discussion 
 
 According to the study, 90 patients were 
divided into 46 males and 44 females. The average 
age was 51.68(+8.75) years, with a minimum age of 
35 and a maximum age of 65. The average weight 
was 67.62(+13.54) kg with a minimum weight of 40 
kg and a maximum weight of 107 kg. The average 
height of 164.14(+7.13) cm with a minimum height 
of 148 cm and a maximum height of 180 cm (see 
Table 1). 
 
Table 1: Demographic data 
Parameters n Mean(+SD) Min Max 
Sex     
  Male 46    
  Female 44    
Age (years)  51.68(+8.75) 35 65 
Weight (Kg)  67.62(+13.54) 40 107 
Height (Cm)  164.14(+7.13) 148 180 
BMI (Kg/m2)  24.94(+3.92) 16.6 35.8 
SBP (mmHg)  127.36(+19.1) 93 185 
DBP (mmHg)  81.16(+11.17) 60 110 
 
 The average of Aspartate aminotransferase 
(AST) was 24.4(+10.48) units per liter with the 
minimum and maximum values of 10 and 70 units 
per liter. The average of Alanine aminotransferase 
(ALT) was 29.28(+16.5) units per liter with the 
minimum and maximum values of 10 and 111 units 
per liter. The average of renal function (Creatinine) 
was 0.84(+0.24) mg/dL with the minimum and 
maximum values of 0.51 and 1.81 mg/dL (see Table 
2).  
 
Table 2: Liver function test (Aspartate 
aminotransferase (AST) and Alamine 
aminotransferase (ALT) and Renal function 
(Creatinine) 
Parameters Mean(+SD) Min Max 
AST (U/L) 24.4(+10.48) 10 70 
ALT (U/L) 29.28(+16.5) 10 111 
Creatinine (mg/dL) 0.84(+0.24) 0.51 1.81 
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 The average HbA1C was 6.44(+1.83) percent, 
with the minimum and maximum HbA1C of 4.1 and 
13 percent. The average of high-sensitivity C-
reactive protein (hs-CRP) was 2.6(+ 2.75) mg/L, 
with the minimum and maximum hs-CRP of 0.21 and 
9.9 mg/L. The average of homocysteine was 
10.26(+0.42) μmol/L with the minimum and 
maximum of 8.9 and 11.2 μmol/L (see Table 3).  
 
Table 3: HbA1C, hs-CRP and homocysteine data 
Parameters Mean(+SD) Min Max 
Hemoglobin 
A1C (%) 
6.44(+1.83) 4.1 13 
hs-CRP 
(mg/L) 
2.6(+2.75) 0.21 9.9 
Homocysteine 
(umol/L) 
10.26(+0.42) 8.9 11.2 
 
From this study, HbA1c was positively 
correlated with high-sensitivity C-reactive protein 
(hs-CRP) with statistically significant (r = 0.33, p = 
0.001). This is consistent with previous study done 
by Amanullah et al. (2010) indicating that high-
sensitivity C-reactive protein (hs-CRP) blood levels 
were significantly higher in people with diabetes than 
in non-diabetic people (p <0.001). In addition, 
HbA1C was positively correlated with high-
sensitivity C-reactive protein (hs-CRP) with 
statistically significant (r = 0.307, p <0.001). Another 
study done by Ramesh et al. (2019) found that in type 
2 diabetes patients, both HbA1C levels and high-
sensitivity C-reactive protein (hs-CRP) were 
statistically related (p = 0.004) (see Table 4).  
Table: 4 Pearson’s Correlation between Hba1c and 
other risk variables in total subjects. 
 
HbA1c was also positively correlated with 
homocysteine with statistically significant (r = 0.53, 
p  < 0.001). This is consistent with previous study 
done by Drzewoski et al. (2000) indicating that 
diabetic patients with poor glycemic control 
(Uncontrolled diabetes) had homocysteine levels 
significantly higher than controlled diabetes patients 
and the healthy control group with p < 0.001. It was 
also found that HbA1c was positively correlated with 
homocysteine in uncontrolled diabetes patients with 
statistically significant (r = 0.41; p < 0.05). In 
addition, previous study done by Bansal et al. (2016) 
found that HbA1c and homocysteine were 
significantly positively correlated (r = 0.416, p 
<0.05). In addition, the present study found that 
HbA1c was positively correlated with the body mass 
index (BMI) with statistically significant (r = 0.34, p 
= 0.001). This is consistent with previous study done 
by Amanullah et al. (2010) indicating that Body mass 
index (BMI) was significantly associated with 
HbA1c (p < 0.001). However, HbA1c was not 




Figure 1: Showing positive correlation between 
HbA1c and High-sensitivity C-reactive protein (hs-
Parameters r p-value 
Hs-CRP 0.33 0.001 
Homocysteine 0.53 <0.001 
BMI 0.34 0.001 
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CRP) (r = 0.33, p = 0.001).
 
 
Figure 2: Showing positive correlation between 
HbA1c and Homocysteine (r = 0.53, p < 0.001). 
 
 
Figure 3: Showing positive correlation between 
HbA1c and body mass index (BMI) (r = 0.34, p = 
0.001). 
Finally, the body mass index (BMI) was 
positively correlated with high-sensitivity C-reactive 
protein (hs-CRP) with statistically significant (r = 
0.33, p = 0.002). This is consistent with previous 
study done by Amanullah et al. (2010) indicating that 
body mass index (BMI) was positively correlated 
with high-sensitivity C-reactive protein (hs-CRP) 
with statistically significant (r = 0.238, p <0.001). In 
addition, the body mass index (BMI) was positively 
correlated with homocysteine  with statistically 
significant (r = 0.32, p = 0.002). This is consistent 
with previous study done by Sachan et al. (2012) 
indicating that  the body mass index (BMI)  was 
associated with homocysteine levels (p <0.001) (see 
Table 5). 
 
Table 5: Pearson’s Correlation between body mass 
index (BMI) and other risk variables in total patients. 
 
Parameters r p-value 
Hs-CRP 0.33 0.002 
Homocysteine 0.32 0.002 
 
Figure 4 : Showing positive correlation between 
body mass index (BMI) and High-sensitivity C-
reactive protein (hs-CRP)  (r = 0.33, p = 0.002). 
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Figure 5: Showing positive correlation between body 
mass index (BMI) and Homocysteine (r = 0.32, p = 
0.002). 
 
 Hyperglycemia is the condition that the body 
has high blood sugar levels results in the  insulin 
resistance and inflammation within the body. It can 
increase the level of inflammatory markers such as 
high-sensitivity C-reactive protein (hs-CRP) and 
homocysteine in the blood. The high-sensitivity C-
reactive protein (hs-CRP) and homocysteine are 
involved in inflammation within the body and also 
are associated with arteriosclerosis diseases such as 
coronary artery disease, stroke and peripheral 
vascular disease (Koenig, 2013). In the present study, 
HbA1c was positively correlated with inflammatory 
markers including hs-CRP and homocysteine with 
statistically significant r = 0.33, p = 0.001; r = 0.53, 
p < 0.001, respectively. In addition, BMI was 
positively correlated with hs-CRP, and homocysteine 
with statistically significant r = 0.33, p = 0.002; 0.32, 
p = 0.002, respectively. These inflammatory markers 
including high-sensitivity C-reactive protein (hs-
CRP) and homocysteine, indicated the risk of 
arteriosclerosis which could lead to vascular disease 
in the future. The high levels of inflammatory 
markers was found not only in those diagnosed with 
diabetes, but also in those with HbA1c diagnosed 
with pre-diabetes (HbA1c 5.7-6.4) which were found 
to have high inflammatory markers. Therefore, if we 
can control HbA1c to normal level (HbA1c < 5.7) 
without focusing only on people with diabetes but  in 
people who are pre-diabetes by adjusting diet and 
exercise to keep HbA1c and weight to normal level, 
it can help to reduce inflammation within the body 
and blood vessels and help reduce arteriosclerosis in 
the future which is an important and common 
complication in patients with hyperglycemia as well.  
Conclusions 
 This study investigated the association between 
HbA1C and inflammatory markers levels including 
hs-CRP and homocysteine. HbA1c was positively 
correlated with hs-CRP and  homocysteine. High 
levels of inflammatory markers were found not only 
in those diagnosed with diabetes but in those with 
HbA1C diagnosed with pre-diabetes. If we can 
control HbA1C to normal level, it can help reduce 
inflammation within the body and blood vessels and 
help reduce arteriosclerosis in the future.   
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